Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sara Moreno-Paz"'
Autor:
Sara Moreno‐Paz, Rianne van derHoek, Elif Eliana, Vitor A. P. Martins dos Santos, Joep Schmitz, Maria Suarez‐Diez
Publikováno v:
Microbial Biotechnology, Vol 17, Iss 3, Pp n/a-n/a (2024)
Abstract Microbial cell factories are instrumental in transitioning towards a sustainable bio‐based economy, offering alternatives to conventional chemical processes. However, fulfilling their potential requires simultaneous screening for optimal m
Externí odkaz:
https://doaj.org/article/2899d32f687444d289eabde6ece42528
Publikováno v:
Microbial Biotechnology, Vol 15, Iss 5, Pp 1434-1445 (2022)
Summary Genome‐scale, constraint‐based models (GEM) and their derivatives are commonly used to model and gain insights into microbial metabolism. Often, however, their accuracy and predictive power are limited and enable only approximate designs.
Externí odkaz:
https://doaj.org/article/42b79b63600c4ebcb5f48aef05c838d7
Autor:
Marta Romo-González, Sara Moreno-Paz, Violeta García-Hernández, Fermín Sánchez-Guijo, Ángel Hernández-Hernández
Publikováno v:
Antioxidants, Vol 9, Iss 1, p 74 (2020)
Chronic myeloid leukemia (CML) is characterized by the expression of the oncogenic kinase BCR-ABL. Although tyrosine kinase inhibitors (TKIs) against BCR-ABL represent the standard therapeutic option for CML, resistances to TKIs can be a serious prob
Externí odkaz:
https://doaj.org/article/8f39626ebc124dd68a2f7be7486730b5
Autor:
Angel Hernández-Hernández, Fermín Sánchez-Guijo, Violeta García-Hernández, Sara Moreno-Paz, Marta Romo-González
Publikováno v:
Antioxidants
Antioxidants, Vol 9, Iss 1, p 74 (2020)
Volume 9
Issue 1
Antioxidants, Vol 9, Iss 1, p 74 (2020)
Volume 9
Issue 1
Chronic myeloid leukemia (CML) is characterized by the expression of the oncogenic kinase BCR-ABL. Although tyrosine kinase inhibitors (TKIs) against BCR-ABL represent the standard therapeutic option for CML, resistances to TKIs can be a serious prob